<SEC-DOCUMENT>0001558370-24-013387.txt : 20241018
<SEC-HEADER>0001558370-24-013387.hdr.sgml : 20241018
<ACCEPTANCE-DATETIME>20241018063559
ACCESSION NUMBER:		0001558370-24-013387
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20241018
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241018
DATE AS OF CHANGE:		20241018

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PTC THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001070081
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				043416587
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35969
		FILM NUMBER:		241378869

	BUSINESS ADDRESS:	
		STREET 1:		500 WARREN CORPORATE CENTER DRIVE
		CITY:			WARREN
		STATE:			NJ
		ZIP:			07059
		BUSINESS PHONE:		9082227000

	MAIL ADDRESS:	
		STREET 1:		500 WARREN CORPORATE CENTER DRIVE
		CITY:			WARREN
		STATE:			NJ
		ZIP:			07059

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PTC THERAPEUTICS INC
		DATE OF NAME CHANGE:	19980909
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tmb-20241018x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.8.0.95 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 10/18/2024 5:48:22 AM -->
<!-- iXBRL Library version: 1.0.9027.2259 -->
<!-- iXBRL Service Job ID: a7a2ee0b-2b3c-40b7-a649-50c7183f9601 -->
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ptct="http://www.ptcbio.com/20241018" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html"/><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" name="dei:EntityCentralIndexKey" id="Tc_63McfaRuf0yhSDW9U6jYnw_2_1">0001070081</ix:nonNumeric><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" name="dei:AmendmentFlag" id="Tc_brWlcF4XEUSukNPtZafoXQ_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="tmb-20241018.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001070081</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-18</xbrli:startDate><xbrli:endDate>2024-10-18</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:2pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_96648a38_c0f7_4684_b696_b5d7445d59a6"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:17pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:17pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">WASHINGTON, D.C. 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:17pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" name="dei:DocumentType" id="Narr_zwNdNa4IKEC69VKo5Y1LAw"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;">Date of Report (Date of earliest event reported): </span><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_DS2heEGtq0ix7ItXgTJP3A"><b style="font-size:9pt;font-weight:bold;">October 18, 2024</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:17pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" name="dei:EntityRegistrantName" id="Narr_4zZ4yrqpxEC0CRjvJIBtlw"><b style="font-weight:bold;">PTC THERAPEUTICS, INC.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Exact Name of Company as Specified in Charter)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_55447ebd_8ac3_48f2_9214_a2803b87ebd3"></a><a id="Tc_uM0TyHXW70ikep47BXyC4A_2_0"></a><a id="Tc_dQ-7AbfNdkKon14WbQYzWw_2_2"></a><a id="Tc_cjSnzIA4t06XKK3YBTBK5A_2_4"></a><a id="Tc_xDB32SBkIku1dn0k0ISFWQ_3_0"></a><a id="Tc_gS3t16g4ZE-0xvc1jpyknw_3_2"></a><a id="Tc_sWaAJbEfZUqJ172QJ8KGZQ_3_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:31.75%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:31.75%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_Gd3V48xCo0Gi1NrJrZLSrw_1_0"><b style="font-size:9pt;font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" name="dei:EntityFileNumber" id="Tc_ss8SViVGCEGOU3k_E6js1A_1_2"><b style="font-size:9pt;font-weight:bold;">001-35969</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" name="dei:EntityTaxIdentificationNumber" id="Tc_3KUVLu7P2Eysf8YHmuQY7g_1_4"><b style="font-size:9pt;font-weight:bold;">04-3416587</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:31.75%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(State or Other Jurisdiction</p></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Commission</p></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(IRS Employer</p></td></tr><tr><td style="vertical-align:bottom;width:31.75%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">of Incorporation)</p></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">File Number)</p></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:31.76%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Identification No.)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><a id="_c0dd52bc_18a5_4ddb_b41a_c697e874a0ff"></a><a id="Tc_99zpch2qmEir-wgMUauR3Q_2_0"></a><a id="Tc_xy7fKTsJ8UuafObFLLZc4A_3_0"></a><a id="Tc_Mdl4Kb6iCk6R-C3SKauoOQ_3_3"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:82.36%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.13%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:47.13%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.13%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" name="dei:EntityAddressAddressLine1" id="Tc_0ce4qYH1SkOkevMtLou10w_1_0"><b style="font-size:9pt;font-weight:bold;">500 Warren Corporate Center Drive</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:47.13%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.13%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" name="dei:EntityAddressCityOrTown" id="Narr_SDsRX_Hh-U6q36jNBlWpNw"><b style="font-size:9pt;font-weight:bold;">Warren</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" name="dei:EntityAddressStateOrProvince" id="Narr_GJPqe9pVbk2FWNjd0aDOtw"><b style="font-size:9pt;font-weight:bold;">NJ</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.13%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" name="dei:EntityAddressPostalZipCode" id="Tc_6SDkr8_LtkKKg18znuhQ0w_2_3"><b style="font-size:9pt;font-weight:bold;">07059</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:47.13%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Address of Principal Executive Offices)</p></td><td style="vertical-align:top;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:47.13%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Zip Code)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;">Registrant&#8217;s telephone number, including area code: </span><b style="font-size:9pt;font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" name="dei:CityAreaCode" id="Narr__l_9JWUTcE2hATofi1Eh8w"><b style="font-size:9pt;font-weight:bold;">908</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" name="dei:LocalPhoneNumber" id="Narr_X6jy3b5la0alM_aRpDJgbw"><b style="font-size:9pt;font-weight:bold;">222-7000</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Not applicable</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Former Name or Former Address, if Changed Since Last Report)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:36pt;margin:0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i style="font-style:italic;">see</i> General Instruction A.2. below):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:21.6pt;"><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_6L6gcDH1KUCqW6HtGYPJuw"><span style="font-family:'Segoe UI Symbol';font-size:9pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span><span style="font-size:9pt;">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:21.6pt;"><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_0HqI63LbVUKPVy6mpxoAdg"><span style="font-family:'Segoe UI Symbol';font-size:9pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span><span style="font-size:9pt;">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:21.6pt;"><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_NEh1ShCmk0C737l5nrowlg"><span style="font-family:'Segoe UI Symbol';font-size:9pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span><span style="font-size:9pt;">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:21.6pt;"><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_vC75P070ZU2hWtgD3_gOrA"><span style="font-family:'Segoe UI Symbol';font-size:9pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span><span style="font-size:9pt;">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_78f9e492_9551_4dcc_bd52_e93e8cab4c26"></a><a id="Tc_lytoYJbvqkyD34y_17e-VA_1_0"></a><a id="Tc_AeznkAiBC0uwFrt1duN_ZA_1_2"></a><a id="Tc_QLd_UMX5LkmHcEXMCZBJDg_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:37.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:19.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:37.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:37.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Title of each class</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:19.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Trading Symbol(s)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:37.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name of each exchange on which registered</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.99%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" name="dei:Security12bTitle" id="Tc_Rda6hyZe40GntqF1YUupIQ_2_0"><span style="font-size:9pt;">Common Stock, $0.001 par value per share</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:19.99%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" name="dei:TradingSymbol" id="Tc_3gPTenkWtUiuaK5CM5RWHQ_2_2"><span style="font-size:9pt;">PTCT</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:37.84%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_oKJaDh_UtUqZh7tEdsW7lQ_2_4"><span style="font-size:9pt;">Nasdaq Global Select Market</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;">Emerging growth company </span><ix:nonNumeric contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_DtV1SWXSYEe1H_BcacYirA"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:2pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_ef00b37e_0b0d_46b9_95e8_1011d7b7e5f4"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Item&#160;7.01.&#160;Regulation FD Disclosure.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="color:#212529;">On October 18, 2024, PTC Therapeutics, Inc. issued a press release announcing that the Committee for Medicinal Products for Human Use of the European Medicines Agency maintained its negative opinion for the renewal of the conditional marketing authorization for Translarna</span><sup style="color:#212529;font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">TM</sup><span style="color:#212529;">&#160;(ataluren) following reexamination, furnished as Exhibit 99.1 to this Report.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="color:#212529;">The information in this Item 7.01 of this Report, including Exhibit 99.1 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. All website addresses given in this Report or incorporated herein by reference are for information only and are not intended to be an active link or to incorporate any website information into this Report.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Item&#160;9.01.&#160;Financial Statements and Exhibits.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">(d)&#160;Exhibits</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:15%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:82.93%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Exhibit&#160;No.</b></p></td><td style="vertical-align:bottom;width:2.06%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:82.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:bottom;width:15%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">99.1</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p></td><td style="vertical-align:bottom;width:82.93%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="tmb-20241018xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Press Release, dated October 18, 2024 issued by PTC Therapeutics, Inc.</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:15%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">104</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:82.93%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The cover page from this Current Report on Form 8-K, formatted in Inline XBRL</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_e8cf83be_f354_496a_84d0_eb6891fd4fb5"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;background:#ffffff;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Signature</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:5.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:44.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">PTC Therapeutics,&#160;Inc.</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: October 18, 2024</p></td><td style="vertical-align:bottom;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:44.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Pierre Gravier</p></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:44.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pierre Gravier</p></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:44.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tmb-20241018xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.125.0--><!--Created on: 10/18/2024 05:48:19 AM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><div style="clear:both;"></div><div style="clear:left;float:left;height:51.12pt;margin-left:5.75pt;margin-right:9pt;width:84.24pt;z-index:251658240;"><div style="height:51.12pt;left:0pt;padding-bottom:0pt;position:relative;width:84.24pt;"><img src="tmb-20241018xex99d1001.jpg" alt="Graphic" style="height:51.12pt;width:84.24pt;"></div></div><p style="font-family:'Aptos';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Exhibit 99.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">CHMP Maintains Negative Opinion on Translarna&#8482; Reexamination</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><i style="font-family:'Arial','Helvetica','sans-serif';font-style:italic;">- Opinion to be reviewed by European Commission -</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt 0pt 0pt 18pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">WARREN, N.J., Oct. 18, 2024</b><font style="font-family:'Arial','Helvetica','sans-serif';"> - PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has maintained its negative opinion on the renewal of the conditional marketing authorization of Translarna&#8482; (ataluren) for the treatment of nonsense mutation Duchenne Muscular Dystrophy (nmDMD) following re-examination. The opinion will now be reviewed by the European Commission (EC) which is expected to decide on opinion adoption in approximately 67 days.</font></p><p style="font-family:'Aptos';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">&#8220;CHMP again based its decision on the results of the primary analysis subpopulation of Study 041 instead of the totality of evidence for Translarna. That evidence includes data across three placebo-controlled trials and our STRIDE registry that demonstrates consistent short and long-term efficacy as well as safety supportive of continued authorization. In addition, the CHMP opinion is clearly against the expressed wishes of physicians, patients and families throughout Europe,&#8221; said Matthew B. Klein, M.D., Chief Executive Officer, PTC Therapeutics, Inc. &#8220;As Translarna will remain authorized in Europe pending review by the European Commission, we will continue to ensure Translarna is available to boys and young men living with nonsense mutation Duchenne muscular dystrophy. In addition, PTC will ensure the EC has all possible evidence to support continued authorization.&#8221;</font></p><p style="font-family:'Aptos';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Aptos';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">About Translarna&#8482; (ataluren)</b></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Translarna (ataluren), discovered and developed by&#160;PTC Therapeutics, is a protein restoration therapy designed to enable the formation of a functioning protein in patients with genetic disorders caused by a nonsense mutation. A nonsense mutation is an alteration in the genetic code that prematurely halts the synthesis of an essential protein. The resulting disorder is determined by which protein cannot be expressed in its entirety and is no longer functional, such as dystrophin in Duchenne. Translarna, the tradename of ataluren, is licensed in multiple countries for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD) in ambulatory patients aged 2 years and older. Ataluren is an investigational new drug in&#160;the United States. </font></p><p style="font-family:'Aptos';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">About Duchenne Muscular Dystrophy (Duchenne)</b><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;"><br></b><font style="font-family:'Arial','Helvetica','sans-serif';">Primarily affecting males, Duchenne is a rare and fatal genetic disorder that results in progressive muscle weakness from early childhood and leads to premature death in the mid-20&#39;s due to heart and respiratory failure. It is a progressive muscle disorder caused by the lack of functional dystrophin protein. Dystrophin is critical to the structural stability of all muscles, including skeletal, diaphragm, and heart muscles. Patients with Duchenne can lose the ability to walk (loss of ambulation) as early as 10 years old, followed by loss of the use of their arms. Duchenne patients subsequently experience life-threatening lung complications, requiring the need for ventilation support, and heart complications in their late teens and 20s.</font></p><p style="font-family:'Aptos';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;background:#ffffff;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">About&#160;PTC Therapeutics, Inc.</b><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;"><br></b><font style="font-family:'Arial','Helvetica','sans-serif';">PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC&#39;s ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. PTC&#39;s mission is to provide access to best-in-class treatments for patients who have little to no treatment options. PTC&#39;s strategy is to leverage its strong scientific and clinical expertise and global commercial infrastructure to bring therapies to patients. PTC believes this allows it to maximize value for all its stakeholders. To learn more about PTC, please visit us at&#160;</font><b style="color:#0000ff;font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">www.ptcbio.com</b><font style="font-family:'Arial','Helvetica','sans-serif';">&#160;and follow us on X, Facebook, Instagram and LinkedIn.</font></p><p style="font-family:'Aptos';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><div style="clear:both;"></div><div style="clear:left;float:left;height:51.12pt;margin-left:5.75pt;margin-right:9pt;width:84.24pt;z-index:251658240;"><div style="height:51.12pt;left:0pt;padding-bottom:0pt;position:relative;width:84.24pt;"><img src="tmb-20241018xex99d1001.jpg" alt="Graphic" style="height:51.12pt;width:84.24pt;"></div></div><p style="font-family:'Aptos';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">For More Information:</b></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;background:#ffffff;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Investors:</b><font style="font-family:'Arial','Helvetica','sans-serif';"><br></font><font style="font-family:'Arial','Helvetica','sans-serif';">Investor Relations</font><font style="font-family:'Arial','Helvetica','sans-serif';"><br></font><font style="font-family:'Arial','Helvetica','sans-serif';">+1 (908) 912-9848</font><font style="font-family:'Arial','Helvetica','sans-serif';"><br></font><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">ir@ptcbio.com&#160;</b></p><p style="font-family:'Aptos';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Media:</b></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Jeanine Clemente</font></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">+1 (908) 912-9406</font></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">jclemente@ptcbio.com </font></p><p style="font-family:'Aptos';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Forward-Looking Statement</b></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this release, other than statements of historic fact, are forward-looking statements, including statements regarding: the future expectations, plans and prospects for PTC, including with respect to the expected timing of clinical trials and studies, availability of data, regulatory submissions and responses, commercialization and other matters with respect to its products and product candidates; PTC&#39;s plans for interactions with the European Medicines Agency (EMA); the European Commission&#8217;s potential adoption of the CHMP&#8217;s negative opinion for Translarna (ataluren); the clinical utility and potential advantages of Translarna (ataluren); PTC&#39;s strategy, future operations, future financial position, future revenues, projected costs; the extent, timing and financial aspects of our strategic pipeline prioritization and reductions in workforce; and the objectives of management. Other forward-looking statements may be identified by the words, &quot;guidance&quot;, &quot;plan,&quot; &quot;anticipate,&quot; &quot;believe,&quot; &quot;estimate,&quot; &quot;expect,&quot; &quot;intend,&quot; &quot;may,&quot; &quot;target,&quot; &quot;potential,&quot; &quot;will,&quot; &quot;would,&quot; &quot;could,&quot; &quot;should,&quot; &quot;continue,&quot; and similar expressions.</font></p><p style="font-family:'Aptos';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">PTC&#39;s actual results, performance or achievements could differ materially from those expressed or implied by forward-looking statements it makes as a result of a variety of risks and uncertainties, including those related to: the outcome of pricing, coverage and reimbursement negotiations with third party payors for PTC&#39;s products or product candidates that PTC commercializes or may commercialize in the future; PTC&#39;s ability to maintain its marketing authorization of Translarna for the treatment of nmDMD in Brazil, Russia, the European Economic Area (EEA) and other regions, or PTC&#8217;s ability to identify other potential mechanisms by which it may provide Translarna to nmDMD patients in the EEA; PTC&#39;s ability to use the clinical data from its international drug registry study and real-world evidence concerning Translarna&#39;s benefits to support a continued marketing authorization for Translarna for the treatment of nmDMD in the EEA; whether investigators agree with PTC&#39;s interpretation of the results of clinical trials and the totality of clinical data from PTC&#39;s trials in Translarna; significant business effects, including the effects of industry, market, economic, political or regulatory conditions; changes in tax and other laws, regulations, rates and policies; the eligible patient base and commercial potential of PTC&#39;s products and product candidates; PTC&#39;s scientific approach and general development progress; and the factors discussed in the &quot;Risk Factors&quot; section of PTC&#39;s most recent Annual Report on Form 10-K, as well as any updates to these risk factors filed from time to time in PTC&#39;s other filings with the SEC. You are urged to carefully consider all such factors.</font></p><p style="font-family:'Aptos';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that any product will receive or maintain regulatory approval in any territory, or prove to be commercially successful, including Translarna.</font></p><p style="font-family:'Aptos';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">The forward-looking statements contained herein represent PTC&#39;s views only as of the date of this press release and PTC does not undertake or plan to update or revise any such forward-looking statements to reflect actual results or changes in plans, prospects, assumptions, estimates or projections, or other circumstances occurring after the date of this press release except as required by law.&#160;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:2.62%;background:#ffffff;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:100%;margin:0pt;padding:0pt 6pt 0pt 6pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Aptos';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:100%;background:#ffffff;margin:0pt;padding:0pt 6pt 0pt 6pt;"><p style="font-family:'Aptos';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;vertical-align:top;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Aptos';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tmb-20241018xex99d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20241018xex99d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !G *D# 2(  A$! Q$!_\0
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M[3Y#F6V6X/\ TW)D'Y-FLVY_97W_ -,UBH?:?W?TB"[\7Z+8DB;4[9&'\/F
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M*?B)I_Q6^'VB>*--D1H=0MUD=$.?*EQ\\9]U;(KJQZ=HOH!UM%%%>0 4444
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M/E;/.1@YJWJNC6&O636>IV-MJ-HQ!:"[B66,D'()5@15RBB[ Q](\':!X?\
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<B@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>tmb-20241018.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.8.0.95 -->
<!--Based on XBRL 2.1-->
<!--Created on: 10/18/2024 5:48:28 AM-->
<!--Modified on: 10/18/2024 5:48:28 AM-->
<xsd:schema targetNamespace="http://www.ptcbio.com/20241018" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:srt-roles="http://fasb.org/srt-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ptct="http://www.ptcbio.com/20241018" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap-ebp="http://fasb.org/us-gaap-ebp/2024">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ptcbio.com/role/DisclosureStandardAndCustomAxisDomainDefaults" id="DisclosureStandardAndCustomAxisDomainDefaults">
        <link:definition>99900 - Disclosure - Standard And Custom Axis Domain Defaults</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="tmb-20241018_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="tmb-20241018_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="tmb-20241018_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>tmb-20241018_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.8.0.95 -->
<!--Based on XBRL 2.1-->
<!--Created on: 10/18/2024 5:48:28 AM-->
<!--Modified on: 10/18/2024 5:48:28 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://www.ptcbio.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:href="tmb-20241018.xsd#DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:definitionLink xlink:role="http://www.ptcbio.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="extended" xlink:title="99900 - Disclosure - Standard And Custom Axis Domain Defaults">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis_1" xlink:title="dei_EntityAddressesAddressTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain_1" xlink:title="dei_AddressTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="dei_EntityAddressesAddressTypeAxis_1" xlink:to="dei_AddressTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:dei_EntityAddressesAddressTypeAxis_1 To dei_AddressTypeDomain_1" order="1" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>tmb-20241018_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.8.0.95 -->
<!--Based on XBRL 2.1-->
<!--Created on: 10/18/2024 5:48:28 AM-->
<!--Modified on: 10/18/2024 5:48:28 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Addresses [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Addresses [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>tmb-20241018_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.8.0.95 -->
<!--Based on XBRL 2.1-->
<!--Created on: 10/18/2024 5:48:28 AM-->
<!--Modified on: 10/18/2024 5:48:28 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="tmb-20241018.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638648273080859648" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_638648273080859648" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638648273080859648" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638648273080859648" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638648273080859648" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_638648273080859648" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638648273080859648" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_638648273080859648" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638648273080859648" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638648273080859648" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638648273080859648" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638648273080859648" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638648273080859648" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638648273080859648" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638648273080859648" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638648273080859648" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638648273080909663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638648273080909663" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638648273080909663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638648273080909663" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638648273080919650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_638648273080919650" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638648273080919650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_638648273080919650" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638648273080919650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_WrittenCommunications_638648273080919650" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638648273080919650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SolicitingMaterial_638648273080919650" order="14" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638648273080919650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_638648273080919650" order="15" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638648273080919650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638648273080919650" order="16" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638648273080919650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_638648273080919650" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638648273080919650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_638648273080919650" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638648273080919650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_638648273080919650" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638648273080929709" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638648273080929709" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638648273080929709" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638648273080929709" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638648273080929709" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_638648273080929709" order="22" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46291558427872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 18, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 18,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PTC THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3416587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 Warren Corporate Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Warren<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">222-7000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PTCT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001070081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MZ^XUPM,M>;KG\#RQ#;<5!3%[H$EMH'"=^7)"EA^G3^/Y].MR-EFTR.QA<HD
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M;%!+ 0(4 Q0    ( 'TT4EDIUGE,[P   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( 'TT4EF97)PC$ 8  )PG
M   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ ?31269)TT\56!   OA   !@              ("!#@@  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( 'TT4EF?H!OPL0(  .(,
M   -              "  9H,  !X;"]S='EL97,N>&UL4$L! A0#%     @
M?31269>*NQS     $P(   L              ( !=@\  %]R96QS+RYR96QS
M4$L! A0#%     @ ?31261PX9>H_ 0  / (   \              ( !7Q
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( 'TT4EDD'INBK0   /@!   :
M              "  <L1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( 'TT4EEED'F2&0$  ,\#   3              "  ; 2  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /H3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="tmb-20241018x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>tmb-20241018.xsd</File>
    <File>tmb-20241018_def.xml</File>
    <File>tmb-20241018_lab.xml</File>
    <File>tmb-20241018_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="tmb-20241018x8k.htm">tmb-20241018x8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tmb-20241018x8k.htm": {
   "nsprefix": "ptct",
   "nsuri": "http://www.ptcbio.com/20241018",
   "dts": {
    "schema": {
     "local": [
      "tmb-20241018.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "tmb-20241018_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "tmb-20241018_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tmb-20241018_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tmb-20241018x8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tmb-20241018x8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tmb-20241018x8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.ptcbio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001558370-24-013387-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-24-013387-xbrl.zip
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M (V:9(_%HK 6Z[DPKYA#N9=XHL^4O(38-^])C?(3(=)0IQ;+@O8$V#1E?"Q
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M*^5MR^E,U11-\KJ*)"43O%@#C$75!W/UIUKFI:.JT)#!ID$-VTTE@L)1U87
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M"ND-Y<M3G5+Q[+"5J F:H+5KZHV524@I\ZBWM_H].7MS_/3PII84<N_A"YK
M^%A7;1K:8G*=NGJ:VZYU":ZW.+7*VV'*1N>5#ZKEI;;FFDN8WS3T =TPSO5T
M5:<V%RS'UL82+TUT(0O.0-5'D>8CJ^:JJ&C'H.S?@GDDQGEW&$V&Q.K4%L-9
MEF8P&<T/8E+[590$+M#D^DJK#7E@RP2LHBVMD_\+8R^AKD0=AF0D-2B.20Q.
M+6+@7!90!;E'3_S*UG,+).1R2<7KF.W4JQH1IDFQQ.__51E_.*U@2T6BPKOZ
M*EE3)[R,5[ +,)L2HZ]?CRFY]8M4!,ZOW1H\;OT:&6N1KE^#X.L7/,!5;3S8
MF,CZ96I5VKABJFQC@N3Z)3?;=EMH7ZJO,AQ@ZZE &EL".%WZ%4HS#Z2:<F]1
MKI6C3WPEL[KX"L=3ED_;5'BC'&XR(_.J(Q'V*%80"#<5S9,M0TG6SZB&N&K5
M("2DXEJP^UO\1'N,=4D% "X5LR"A"68NK58![:UVEP&&J0O;4D#T>KT,&@3@
MK 9WUX2P92H/].=$/_P?P#NE<!"SZ $"=#ZNK&-I"#X-E4;:X*TM$%%:3_T8
M2QSEZPA7(W\=)"C5?RU&A.H$)<_7ZAE\-R'$>I4C4H@ AX?;2REU6SA'J#_4
MX7U#@PIUG-",/UGYN\XZXKR"0\5>F"82G<$+30X8/<:SB%5GQT];P9.Z6QG;
M:XW$*-2N_-35GO#$*K3D*@%QT2YWJ]X?MH5E4V!I+8%J)2QP4TV)NH)$-RBJ
MBC7M)L1Q&R\;J^;G8<!%W2K#;3)-LZ[C+N)@'C+K K%A^$V+)50"&V22U^YQ
MX_G;E;.Z#U.V.C%OVK"-,'W[CC7K7LP4:W75^$/V*:?4HLS6NU(,+Q?.Z66;
M.[3ZJ[>QK\W&Z2VJ7,T0G]/M+Z\="NIVH^(4 I@85TYS$X?B?I$-]U7U99I)
M%VE%6]&)&NL(%2T1&&6RV#!A;)L!-E]] %\@VYJJ8"7RJF6RF5RXAC?&W@%V
MU$!\,F"$JOE&IJ?<7!MMCOO4-ZJL+8.&U%M0X>/4L5W H^\G2&I;HY(=3(EZ
M0-HEWKH39<50B.'3IE--N*J;Y.B#$#7/ 9Q4>Z)[8AQU*JE-H%7A!,V"5NB;
M7>*X*"@FG"NV7MSY,YU1AH/NWSOM9G0J3%=E1#DF]82_-%\MTT138WP(#SKG
M&B/_AH2KF<.VX%9808LPOS\[Z8E_FHH/+Y6=AH[)!.\F52@/%TY3 PZ5&;G5
M+\[ZT%LU_FI<XCAN&IG#1OM"5= &M>R7@PN5??&O#0PAO$?#7;N_Y=[L''.B
M^C?U.5!#0>UXW'8:IRJ,F%82H.15'9%9VNB6\0L$B>)SDUU%V&V34UL!GO7T
MWT+0)YT8]^<J?E%S)5E&AU+N$8#)MK&N]963;\;ZE=,[MV5"6KD6LAVV .*S
M!(HKP*(OD5!5/S3 Q4!*,!A>7\L?D;D2 4R-HE9E']R"FB+8='#48[92AB$L
M?TV%'UM&7+M97CP'/,PH9;%.Y&F<5@CD[$1GE:0A''=57L8 6)\7:P[[6X@0
M@=<%?$ZT3:H<4X/ZX+8DJ2QWBW#E^V,:4%>)*CUI*[3IQ09!N>BMMWB0G5 1
MD[]EC%.7FGCZSTJX2;[N! CU],1DF2R=&M4OVB9$B=IH/53\I$V%MM;+Z^UZ
M<JA3KPKE.[V]G>^V%0E)F*8GH;;/8),^;4JVU'4#](O?E0Z>TB[!MXPY2L!Y
MYKV89XYIYNOU<)J)3BZ3S"QJ5ZO?=Q=6EJ/0C$#YA8^V"&RKH<NQ,UGEU4:_
MP.?#4H,732)]/_S>ZL5AE,]K%>G[E'Y8VJ!/VHS;2\&W[,__4[!>UX<WY1_6
M=J/A/CODW1L?_K!U/+#6H;OW"<V-3C_6)M0/_QL3__=.+_\/4$L! A0#%
M  @ ?31265)1^-G- P  8 \  !               ( !     '1M8BTR,#(T
M,3 Q."YX<V102P$"% ,4    " !]-%)9$74/:=\"  #X"@  %
M    @ '[ P  =&UB+3(P,C0Q,#$X7V1E9BYX;6Q02P$"% ,4    " !]-%)9
MGH3]G;(%  "E0   %               @ $,!P  =&UB+3(P,C0Q,#$X7VQA
M8BYX;6Q02P$"% ,4    " !]-%)9ORP=4G<$  "Y)0  %
M@ 'P#   =&UB+3(P,C0Q,#$X7W!R92YX;6Q02P$"% ,4    " !]-%)9[+!5
M> \6  !WK   $P              @ &9$0  =&UB+3(P,C0Q,#$X>#AK+FAT
M;5!+ 0(4 Q0    ( 'TT4ED6^XJI&!(  +1*   7              "  =DG
M  !T;6(M,C R-#$P,3AX97@Y.60Q+FAT;5!+!08     !@ & (H!   F.@
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>tmb-20241018x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tmb-20241018.xsd" xlink:type="simple"/>
    <context id="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001070081</identifier>
        </entity>
        <period>
            <startDate>2024-10-18</startDate>
            <endDate>2024-10-18</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Tc_63McfaRuf0yhSDW9U6jYnw_2_1">0001070081</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Tc_brWlcF4XEUSukNPtZafoXQ_3_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Narr_zwNdNa4IKEC69VKo5Y1LAw">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Narr_DS2heEGtq0ix7ItXgTJP3A">2024-10-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Narr_4zZ4yrqpxEC0CRjvJIBtlw">PTC THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Tc_Gd3V48xCo0Gi1NrJrZLSrw_1_0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Tc_ss8SViVGCEGOU3k_E6js1A_1_2">001-35969</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Tc_3KUVLu7P2Eysf8YHmuQY7g_1_4">04-3416587</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Tc_0ce4qYH1SkOkevMtLou10w_1_0">500 Warren Corporate Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Narr_SDsRX_Hh-U6q36jNBlWpNw">Warren</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Narr_GJPqe9pVbk2FWNjd0aDOtw">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Tc_6SDkr8_LtkKKg18znuhQ0w_2_3">07059</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Narr__l_9JWUTcE2hATofi1Eh8w">908</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Narr_X6jy3b5la0alM_aRpDJgbw">222-7000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Narr_6L6gcDH1KUCqW6HtGYPJuw">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Narr_0HqI63LbVUKPVy6mpxoAdg">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Narr_NEh1ShCmk0C737l5nrowlg">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Narr_vC75P070ZU2hWtgD3_gOrA">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Tc_Rda6hyZe40GntqF1YUupIQ_2_0">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Tc_3gPTenkWtUiuaK5CM5RWHQ_2_2">PTCT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Tc_oKJaDh_UtUqZh7tEdsW7lQ_2_4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_10_18_2024_To_10_18_2024_40IXk_KvaEizwCsqmyqdXA"
      id="Narr_DtV1SWXSYEe1H_BcacYirA">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
